Order Article Reprints

Dunn J, McCuaig RD, Tan AHY, Tu WJ, Wu F, Wagstaff KM, Zafar A, Ali S, Diwakar H, Dahlstrom JE, et al. Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8⁺ T Cells in Immunotherapy-Resistant and Metastatic Cancers. Cancers. 2022; 14(6):1596. https://doi.org/10.3390/cancers14061596

Dunn, Jenny, Robert D. McCuaig, Abel H. Y. Tan, Wen Juan Tu, Fan Wu, Kylie M. Wagstaff, Anjum Zafar, Sayed Ali, Himanshu Diwakar, Jane E. Dahlstrom, and et al. 2022. "Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8⁺ T Cells in Immunotherapy-Resistant and Metastatic Cancers" Cancers 14, no. 6: 1596. https://doi.org/10.3390/cancers14061596

Dunn, J., McCuaig, R. D., Tan, A. H. Y., Tu, W. J., Wu, F., Wagstaff, K. M., Zafar, A., Ali, S., Diwakar, H., Dahlstrom, J. E., Bean, E. G., Forwood, J. K., Tsimbalyuk, S., Cross, E. M., Hardy, K., Bain, A. L., Ahern, E., Dolcetti, R., Mazzieri, R., ... Rao, S. (2022). Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8⁺ T Cells in Immunotherapy-Resistant and Metastatic Cancers. Cancers, 14(6), 1596. https://doi.org/10.3390/cancers14061596